ARTICLE | Clinical News
Vical preclinical data
April 3, 2006 7:00 AM UTC
A Vaxfectin-formulated DNA vaccine targeting influenza nucleoprotein and matrix protein protected mice against lethal challenges of the H1N1 or H3N2 strains of human influenza virus. Preclinical testi...